Andrew P. Hider - 02 Sep 2025 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
President and CEO, Director
Signature
/s/ Ellen K. Bradford, as attorney in-fact for Andrew P. Hider
Issuer symbol
BAX
Transactions as of
02 Sep 2025
Net transactions value
$0
Form type
4
Filing time
04 Sep 2025, 18:01:54 UTC
Previous filing
25 Aug 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hider Andrew P. President and CEO, Director ONE BAXTER PARKWAY, DEERFIELD /s/ Ellen K. Bradford, as attorney in-fact for Andrew P. Hider 04 Sep 2025 0001940945

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BAX Common Stock, $1 par value Award $0 +236,237 $0.000000 236,237 02 Sep 2025 Direct F1
transaction BAX Common Stock, $1 par value Award $0 +131,813 +56% $0.000000 368,050 02 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BAX Stock Option (Right to Buy) Award $0 +465,651 $0.000000 465,651 02 Sep 2025 Common Stock, $1 par value 465,651 $24.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received a grant of restricted stock units (RSUs) as compensation for the unvested portion of certain equity awards previously granted by the reporting person's prior employer (the Make Whole Award). The Make Whole Award is scheduled to vest in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. (Baxter) 2021 Amended and Restated Incentive Plan (the Plan). Any outstanding and unvested portion of the Make Whole Award will immediately vest if the reporting person's employment is terminated by Baxter other than for Cause (as defined in Baxter's Executive Severance Plan) or by the reporting person for Good Reason (as defined in the Offer Letter, effective as of July 7, 2025, by and between the reporting person and Baxter).
F2 The reporting person received RSUs as a pro rata grant under Baxter's 2025 annual equity incentive compensation program that are scheduled to vest in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Plan.
F3 The reporting person received stock options as a pro rata grant under Baxter's 2025 annual equity incentive compensation program, with such options becoming exercisable in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to the terms of the Plan.